Is compounded semaglutide legit and safe

TLDR. Compounded semaglutide is legal in the United States when a state-licensed compounding pharmacy prepares it against a valid prescription. That covers 503A pharmacies making a patient-specific formula and 503B outsourcing facilities working under stricter federal oversight. It is not FDA-approved, because the FDA does not approve compounded drugs at all. It spread during the 2022 to 2025 semaglutide shortage. With semaglutide now off the FDA shortage list, mass compounding is more restricted, and most legitimate access runs through 503A patient-specific compounding tied to a prescriber. Whether a given product is safe depends on the pharmacy that makes it. The cheapest legitimate route costs about $149 to $178 a month.

Is compounded semaglutide legal?

Yes, within limits set by federal law. Semaglutide is the active ingredient in Ozempic and Wegovy, both made by Novo Nordisk. A compounding pharmacy can prepare a semaglutide product when two things are true at once: the pharmacy holds a state license, and a licensed prescriber has written a valid prescription for the patient.

The FDA recognizes two categories of compounder. A 503A pharmacy compounds a drug for an individual patient based on that patient's prescription. A 503B outsourcing facility registers with the FDA, follows federal manufacturing standards, and can make larger batches. Both operate under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act, described on the FDA's human drug compounding pages.

The prescription part carries weight. A legitimate program routes you through a medical consultation, and a prescriber decides whether compounded semaglutide is appropriate for you. A seller that ships semaglutide with no prescriber involved is working outside that framework.

Why it is not FDA-approved

Compounded drugs are never FDA-approved. That holds for every compounded medicine, not only semaglutide. The FDA states that it does not verify the safety, effectiveness, or quality of compounded drugs before they reach patients. What the agency does review is the bulk ingredients a compounder may use, plus the pharmacies and outsourcing facilities themselves.

So the phrase some sites use, "FDA-approved compounded semaglutide," describes something that does not exist. The finished compound is not approved. The brand versions, Ozempic and Wegovy, hold FDA approval, and a compounded copy does not inherit it.

What changed after the shortage ended

Wide-scale compounding of semaglutide was tied to a shortage. When the FDA lists a drug as in shortage, compounders gain more room to make copies of it, because patients cannot get the approved product. Semaglutide sat on that shortage list from 2022 into 2025.

The FDA declared the semaglutide shortage resolved in 2025. Once a drug comes off the shortage list, the room for compounding narrows, and the agency set transition periods before enforcement resumed. 503B outsourcing facilities lose most of their basis for making copies of a drug that is again commercially available. A 503A pharmacy can still compound a patient-specific formula when a prescriber documents a clinical reason, such as a needed change in dose or the removal of an ingredient a patient cannot tolerate.

The practical result is that most legitimate compounded semaglutide today comes through 503A patient-specific compounding tied to a prescriber, rather than mass-produced vials sold to anyone who fills out a form.

How to tell a legitimate pharmacy from a red-flag seller

The gap between a legitimate program and a risky one usually comes down to the pharmacy behind the product. A few checks help:

• A named US pharmacy license. A legitimate program uses a US state-licensed pharmacy and will tell you which one. You can confirm a license with the state pharmacy board.
• A real prescription. There should be a medical intake and a licensed prescriber. No prescriber is a red flag.
• The right form of semaglutide. The FDA has warned about compounders using salt forms, semaglutide sodium and semaglutide acetate, which differ from the semaglutide base in the approved drugs. Avoid products that list a salt form.
• No "research use only" labeling. Any vial marked "research use only" or "not for human consumption" is not a medicine. It is sold to get around pharmacy law, and you have no assurance of what is in it.

If a seller cannot tell you which licensed pharmacy makes the product, treat that silence as your answer.

What it costs

Compounded semaglutide is the cheapest legitimate route to the drug right now. Programs that use licensed US pharmacies generally price it around $149 to $178 a month before any promotional discount. Brand Wegovy through Novo Nordisk's cash program costs more than that, and the number moves with your dose.

We track the live figures program by program, so treat the ranges here as a starting point and check the current price before you commit.

See how the compounded programs stack up in our compounded pharmacy comparison, weigh every option side by side on the full chart, or go straight to the cheapest GLP-1 programs.

Common questions

Is compounded semaglutide FDA-approved? No. The FDA does not approve compounded drugs of any kind. It reviews the ingredients compounders may use and inspects the pharmacies, not the finished product.

Is compounded semaglutide safe? It depends on the pharmacy. A product from a US-licensed compounding pharmacy using pharmaceutical-grade semaglutide against a valid prescription is a different thing from a "research use only" vial sold with no prescriber. The FDA has flagged safety concerns tied to salt forms and unlicensed sellers. Ask a prescriber whether it fits your health situation.

Is it still legal now that the shortage is over? Yes, through 503A patient-specific compounding when a prescriber documents a clinical reason. What narrowed after the shortage ended was large-scale copying of the drug, especially by 503B outsourcing facilities, now that semaglutide is commercially available again.